Preparation and characterization of protein C-loaded PLA nanoparticles

被引:149
作者
Zambaux, MF
Bonneaux, F
Gref, R
Dellacherie, E
Vigneron, C
机构
[1] Fac Pharm, Lab Hematol Physiol, F-54001 Nancy, France
[2] Ecole Natl Super Ind Chim, Lab Chim Phys Macromol, CNRS, UMR 7568,INPL, F-54001 Nancy, France
[3] Fac Pharm, Pharm Galen & Biopharm Lab, CNRS, URA 1218, F-92296 Chatenay Malabry, France
关键词
biodegradable nanoparticles; poly (lactic acid); protein C; protein delivery; protein stability;
D O I
10.1016/S0168-3659(99)00073-5
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
This paper deals with the preparation and the characterization of poly(lactic acid) (PLA) nanoparticles containing protein C, a plasma inhibitor, Nanoparticles were prepared by the double emulsion method (w/o/w), using methylene chloride as an organic solvent and polyvinyl alcohol (PVA) or human serum albumin (HSA) as a surfactant. The influence of experimental constraints such as sonication and organic solvent on protein C activity was evaluated. It appears that a short time of sonication as well as the addition of acetone to methylene chloride (1/1) limited the lost of protein C activity. The study of protein C adsorption on blank PLA nanoparticles gave evidence to hydrophobic interactions between these two entities. The increase in PLA molecular weight on the characteristics of the protein C-loaded nanoparticles led to both a slightly decreased particle size and a lower polydispersity index, whereas the entrapment efficiency of protein C was not affected. The use of HSA as a surfactant allowed the increase in the entrapment efficiency of protein C but prevented its release. Finally, the evaluation of the activity of released protein C clearly illustrates that it was disturbed during the nanoparticle preparation. Thus, the obtained results emphasize the potential of protein C-loaded biodegradable nanoparticles for protein progressive delivery in plasma. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:179 / 188
页数:10
相关论文
共 27 条
[1]   In vitro degradation of nanospheres from poly(D,L-lactides) of different molecular weights and polydispersities [J].
Belbella, A ;
Vauthier, C ;
Fessi, H ;
Devissaguet, JP ;
Puisieux, F .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1996, 129 (1-2) :95-102
[2]   Development and characterization of protein-loaded poly(lactide-co-glycolide) nanospheres [J].
Blanco, MD ;
Alonso, MJ .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 1997, 43 (03) :287-294
[3]   THE EFFECT OF THE ADDITION OF LOW-MOLECULAR WEIGHT POLY(DL-LACTIDE) ON DRUG RELEASE FROM BIODEGRADABLE POLY(DL-LACTIDE) DRUG DELIVERY SYSTEMS [J].
BODMEIER, R ;
OH, KH ;
CHEN, H .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1989, 51 (01) :1-8
[4]  
COUVREUR P, 1985, FORMES PHARM NOUVELL, P577
[5]   Stability and release of bovine serum albumin encapsulated within poly(D,L-lactide-co-glycolide) microparticles [J].
Crotts, G ;
Park, TG .
JOURNAL OF CONTROLLED RELEASE, 1997, 44 (2-3) :123-134
[6]  
DELUCA PP, 1988, Patent No. 4741872
[7]  
FernandezUrrusuno R, 1996, J BIOMED MATER RES, V31, P401, DOI 10.1002/(SICI)1097-4636(199607)31:3<401::AID-JBM15>3.0.CO
[8]  
2-L
[9]   QUALITY IMPROVEMENT OF SPRAY-DRIED, PROTEIN-LOADED D,L-PLA MICROSPHERES BY APPROPRIATE POLYMER-SOLVENT SELECTION [J].
GANDER, B ;
WEHRLI, E ;
ALDER, R ;
MERKLE, HP .
JOURNAL OF MICROENCAPSULATION, 1995, 12 (01) :83-97
[10]  
GUILLIN MC, 1987, PRESSE MED, V16, P468